A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides

New England Journal of Medicine

Volumn 321, Issue 26, 1989, Pages 1784-1790

  Kaye, Frederic J ^a   Bunn, Paul A ^a   Steinberg, Seth M ^a   Stocker, Joyce L ^a   Ihde, Daniel C ^a   Fischmann, A B ^a   Glatstein, Eli J ^a   Schechter, Geraldine P ^a   Phelps, Ruby M ^a   Foss, Francine M ^a   Parlette, Harry L ^a   Anderson, Michael J ^a   Sausville, Edward A ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTRON BEAM; ELECTRON RADIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; TOPICAL DRUG ADMINISTRATION;

EID: 0024840027     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198912283212603     Document Type: Article

References (44)

1. Lutzner M, Edelson RL, Schein P, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: the Sezary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975; 83: 534–52.
2. Broder S, Edelson RL, Lutzner MA, et al. The Sezary syndrome: a malignant proliferation of helper T cells. J Clin Invest 1976; 58: 1297–306.
3. Broder S, Bunn PA Jr. Cutaneous T-cell lymphomas. Semin Oncol 1980; 7: 310–31.
4. Winkler CF, Bunn PA Jr. Cutaneous T-cell lymphoma: a review. CRC Crit Rev Oncol Hematol 1983; 1: 49–92.
5. Bunn PA Jr, Huberman MS, Whang-Peng J, et al. Prospective staging evaluation of patients with cutaneous T-cell lymphomas: demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med 1980; 93: 223–30.
6. Sausville EA, Eddy JL, Makuch RW, et al. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Ann Intern Med 1988; 109: 372–82.
7. Henstell HH, Tober JN. Treatment of mycosis fungoides with nitrogen mustard. J Invest Dermatol 1947; 8: 183–8.
8. Vonderheid EC. Topical mechlorethamine chemotherapy: considerations on its use in mycosis fungoides. Int J Dermatol 1984; 23: 180–6.
9. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683–9.
10. Gilchrest BA. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat Rep 1979; 63: 663–7.
11. Roenigk HH Jr. Photochemotherapy for mycosis fungoides: long-term follow up study. Cancer Treat Rep 1979; 63: 669–73.
12. Hoppe RT, Cox RS, Fuks Z, Price NM, Bagshaw MA, Farber EM. Electron-beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979; 63: 691–700.
13. Tadros AA, Tepperman BS, Hryniuk WM, et al. Total skin electron irradiation for mycosis fungoides: failure analysis and prognostic factors. Int J Radiat Oncol Biol Phys 1983; 9: 1279–87.
14. Van Vloten WA, De Vroome H, Noordijk EM. Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides). Br J Dermatol 1985; 112: 697–702.
15. Leavell UW Jr, DeSimone P. Combined chemotherapy (COP) in treatment of mycosis fungoides: report of four cases. South Med J 1976; 69: 915–7.
16. Grozea PN, Jones SE, McKelvey EM, Coltman CA Jr, Fisher R, Haskins CL. Combination chemotherapy for mycosis fungoides: a Southwestern Oncology Group study. Cancer Treat Rep 1979; 63: 647–53.
17. Groth O, Molin L, Thomsen K. Tumour stage of mycosis fungoides treated with bleomycin and methotrexate: report from the Scandinavian mycosis fungoides study group. Acta Derm Venereol (Stockh) 1979; 59: 59–63.
18. Tirelli U, Carbone A, Veronesi A, et al. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides. Cancer Treat Rep 1982; 66: 167–9.
19. Winkler CF, Sausville EA, Ihde DC, et al. Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up. J Clin Oncol 1986; 4: 1094–100.
20. Griem ML, Tokars RP, Petras V, Variakojis D, Baron JM, Griem SF. Combined therapy for patients with mycosis fungoides. Cancer Treat Rep 1979; 63: 655–7.
21. Hallahan DE, Griem ML, Griem SF, et al. Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up. J Clin Oncol 1988; 6: 1177–83.
22. Braverman IM, Yager NB, Chen M, Cadman EC, Hait WN, Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. J Am Acad Dermatol 1987; 16: 45–60.
23. Zubrod CG, Schneiderman M, Frei E III, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trials of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960; 11: 7–33.
24. Schechter GP, Sausville EA, Fischmann AB, et al. Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma. Blood 1987; 69: 841–9.
25. Bunn PA Jr, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-cell Lymphomas. Cancer Treat Rep 1979; 63: 725–8.
26. Sausville EA, Worsham GF, Matthews MJ, et al. Histologie assessment of lymph nodes in mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol 1985; 16: 1098–109.
27. Lesser ML. Design and implementation of clinical trials. In: Miké V, Stanley KE, eds. Statistics in medical research: methods and issues, with applications in cancer research. New York: John Wiley, 1982:225–53.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70.
30. Vonderheid EC, Van Scott EJ, Wallner PE, Johnson WC. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy. Cancer Treat Rep 1979; 63: 681–9.
31. Kaye F, Ihde D, Fischmann A, et al. A randomized trial comparing conservative and aggressive therapy in mycosis fungoides. Proc Am Soc Clin Oncol 1986; 5: 195. abstract.
32. Jones DB, Kaye F, Hardman J, et al. The eosinophilic variant of acute myelomonocytic leukemia developing as a secondary leukemia in a patient with mycosis fungoides. Hematol Pathol 1987; 1: 67–76.
33. Hoppe RT, Fuks Z, Bagshaw MA. Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 625–32.
34. Portlock CS, Rosenberg SA. No initial therapy for stage III and IV nonHodgkin's lymphomas of favorable histologic types. Ann Intern Med 1979; 90: 10–3.
35. Horning SJ, Rosenberg SA. The natural history of initially untreated lowgrade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471–5.
36. Lynfield VL, Esseesse I, Dorf B, Paltzik R. Mycosis fungoides terminating in acute myelomonocytic leukemia. N Y State J Med 1980; 80: 798–800.
37. Waddell CC, Zubler MA, Gore WS. Acute myeloblastic leukemia following chemotherapy for mycosis fungoides. Arch Dermatol 1982; 118: 179–82.
38. Resnick L, Schleider-Kushner N, Horwitz SN, Frost P. Remission of tumor-stage mycosis fungoides following intravenously administered acyclovir. JAMA 1984; 251: 1571–3.
39. Bunn PA Jr, Foon KA, Ihde DC, et al. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 1984; 101: 484–7.
40. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987; 316: 297–303.
41. Claudy AL, Rouchouse B, Boucheron S, Le Petit JC. Treatment of cutaneous lymphoma with etretinate. Br J Dermatol 1983; 109: 49–56.
42. Kessler JF, Meyskens FL Jr, Levine N, Lynch PJ, Jones SE. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1983; 1: 1345–7.
43. Grever MR, Bisaccia E, Scarborough DA, Metz EN, Neidhart JA. An investigation of 2′-deoxycoformycin in the treatment of cutaneous T-cell lymphoma. Blood 1983; 61: 279–82.
44. Dillman RO, Shawler DL, Dillman JB, Royston I. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody. J Clin Oncol 1984; 2: 881–91.